Of All Antioxidants, Would One Finally Be Used Clinically For Atherosclerotic Disease?

  • Suko Adiarto Departemen Kardiologi dan Kedokteran Vaskular FKUI, Pusat Jantung Nasional Harapan Kita, Jakarta.

Abstract

Oxidation of LDL by oxygen free radicals results in unregulated uptake of modified LDL by macrophages in arterial wall. This is considered a key initiating factor for development and progression of atherosclerotic process. It is then logical to hypothesize that anti-oxidants, which can directly scavenge free radicals, can be useful in preventing atherosclerotic process. Initial support for this hypothesis accumulated rapidly from numerous in-vitro studies.

Downloads

Download data is not yet available.

References

Hendarto, Rochman S, Sargowo D. Mangosteen Pericarp Inhibits Nuclear Factor ?B (NF-?B) Activation and Reduces Expression of ICAM-1 in High Cholesterol diet rat. J Kardiol Indones. 2013;34:23-32

Reddy KS. Diet and Cardiovascular Disease. In: Yusuf S, Cairn JA, Fallen EL, Gersh BJ, eds. Evidence-based Cardiology, 3rd ed. Singapore 2010: 111-124

Jialal I, Devaraj S. Antioxidants and Atherosclerosis: Don’t Throw 3. Out the Baby With the bath water. Circulation. 2003;107:926-928

Diaz nm, Frei b, Vita ja, Keaney jf. Antioxidants and atherosclerotic heart disease. N eng J Med. 1997;107:410-416
Published
2013-10-16
Views & Downloads
Abstract views: 2682   
PDF downloads: 1819   
How to Cite
Adiarto, S. (2013). Of All Antioxidants, Would One Finally Be Used Clinically For Atherosclerotic Disease?. Indonesian Journal of Cardiology, 34(1), 33-4. https://doi.org/10.30701/ijc.v34i1.303